CTRI/2024/04/065489Not yet recruitingUnknown
A Study On Clinical Profile And Outcome Of Thrombotic Microangiopathy - TMA
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with thrombotic microangiopathy and its causes will be recruited after taking consent
Exclusion Criteria
- •secondary causes related to pregnancy will and age less than 18 yrs will be excluded
Investigators
Similar Trials
Completed
Phase 2
Platenza Tablets for Dengue feverCTRI/2018/02/011789The Himalaya Drug Company40
Not yet recruiting
Not Applicable
A study of thromboembolic events in patients of advanced stage lung cancer treated with platinum based chemotherapy.CTRI/2014/11/005227Tata Memorial Hospital167
Completed
Phase 2
Platenza Tablets for Dengue feverCTRI/2018/03/012738The Himalaya Drug Company60
Completed
Phase 2
Tablets for dengueCTRI/2018/03/012697The Himalaya Drug Company Ltd60
Recruiting
Not Applicable
The retrospective study of treatment by thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis, acute respiratory distress sydmromeacute exacerbations of idiopathic pulmonary fibrosis, acute respiratory distress syndromeJPRN-UMIN000012590Chiba University50